Clinical management of community acquired pneumonia in the elderly patient

Community-Acquired Pneumonia Due to Multidrug- and Non–Multidrug-Resistant Pseudomonas aeruginosa

(2016) Catia Cillóniz et al.   CHEST

Efficacy and Safety of Corticosteroids for Community-Acquired Pneumonia

(2016) You-Dong Wan et al.   CHEST

Statin Use and Hospital Length of Stay Among Adults Hospitalized With Community-acquired Pneumonia

(2016) Fiona Havers et al.   CLINICAL INFECTIOUS DISEASES

Computed Tomography for the Diagnosis and Evaluation of the Severity of Community-acquired Pneumonia in the Elderly

(2016) Takahiro Haga et al.   INTERNAL MEDICINE

Procalcitonin-based indication of bacterial infection identifies high risk acute heart failure patients

(2016) Biniyam G. Demissei et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

The prognostic significance of admission blood glucose levels in elderly patients with pneumonia (GAP Study)

(2016) Amit Akirov et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Community-Acquired Pneumonia in Elderly Adults with Type 2 Diabetes Mellitus

(2016) Diamantis P. Kofteridis et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Lung ultrasound and chest x-ray for detecting pneumonia in an acute geriatric ward

(2016) Andrea Ticinesi et al.   MEDICINE

Increasing burden of community-acquired pneumonia leading to hospitalisation, 1998–2014

(2016) T Phuong Quan et al.   THORAX

Ten-Year Mortality after Community-acquired Pneumonia. A Prospective Cohort

(2015) Dean T. Eurich et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia

(2015) Reed A.C. Siemieniuk et al.   ANNALS OF INTERNAL MEDICINE

Optimizing clinical use of biomarkers in high-risk acute heart failure patients

(2015) Biniyam G. Demissei et al.   EUROPEAN JOURNAL OF HEART FAILURE

Tuberculosis among older adults – time to take notice

(2015) Joel Negin et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial

(2015) Claudine Angela Blum et al.   LANCET

Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

(2015)   LANCET

Antibiotic Treatment Strategies for Community-Acquired Pneumonia in Adults

(2015) Douwe F. Postma et al.   NEW ENGLAND JOURNAL OF MEDICINE

Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults

(2015) Seema Jain et al.   NEW ENGLAND JOURNAL OF MEDICINE

Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis

(2015) Mark H. Rozenbaum et al.   VACCINE

The effect of simvastatin on inflammatory cytokines in community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial

(2015) D. Viasus et al.   BMJ Open

Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

(2015) Miwako Kobayashi et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With Pneumonia

(2014) Eric M. Mortensen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Risk of Hospitalization for Community Acquired Pneumonia with Renin-Angiotensin Blockade in Elderly Patients: A Population-Based Study

(2014) Sachin Shah et al.   PLoS One

β-Lactam Monotherapy vs β-Lactam–Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia

(2014) Nicolas Garin et al.   JAMA Internal Medicine

Impact of Age and Comorbidity on Cause and Outcome in Community-Acquired Pneumonia

(2013) Catia Cillóniz et al.   CHEST

The management of community-acquired pneumonia in the elderly

(2013) Paola Faverio et al.   European Journal of Internal Medicine

Distribution of 13-Valent Pneumococcal Conjugate Vaccine Streptococcus pneumoniae Serotypes in US Adults Aged >=50 Years With Community-Acquired Pneumonia

(2013) R. L. Sherwin et al.   JOURNAL OF INFECTIOUS DISEASES

Atualização em pneumonia comunitária viral

(2013) Ozéas Galeno da Rocha Neto et al.   Revista da Associacao Medica Brasileira

Pneumonia in the Community Caused by Multidrug-Resistant Organisms: Keep Working on Probabilistic Scores

(2012) S. Aliberti et al.   CLINICAL INFECTIOUS DISEASES

Macrolide-Based Regimens and Mortality in Hospitalized Patients With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis

(2012) Leyla Asadi et al.   CLINICAL INFECTIOUS DISEASES

Population-Based Study of Statins, Angiotensin II Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors on Pneumonia-Related Outcomes

(2012) E. M. Mortensen et al.   CLINICAL INFECTIOUS DISEASES

Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial

(2012) Conroy Wong et al.   LANCET

Outcomes in elderly Danish citizens admitted with community-acquired pneumonia. Regional differencties, in a public healthcare system

(2012) H.H. Klausen et al.   RESPIRATORY MEDICINE

Guidelines for the management of adult lower respiratory tract infections - Summary

(2011) M. Woodhead et al.   CLINICAL MICROBIOLOGY AND INFECTION

Community-acquired pneumonia in younger patients is an entity on its own

(2011) Benjamin Klapdor et al.   EUROPEAN RESPIRATORY JOURNAL

Immunomodulatory effects of macrolides during community-acquired pneumonia: a literature review

(2011) A. Kovaleva et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Azithromycin for Prevention of Exacerbations of COPD

(2011) Richard K. Albert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nursing-home-acquired pneumonia in Germany: an 8-year prospective multicentre study

(2011) Santiago Ewig et al.   THORAX

Effect of Azithromycin on Pulmonary Function in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosaA Randomized Controlled Trial

(2010) Lisa Saiman   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Comparison of clinical characteristics and performance of pneumonia severity score and CURB-65 among younger adults, elderly and very old subjects

(2010) J.-H. Chen et al.   THORAX

Nursing home-acquired pneumonia: a 10 year single-centre experience

(2010) E Polverino et al.   THORAX

Clinical and economic burden of community-acquired pneumonia among adults in Europe

(2010) T Welte et al.   THORAX

Predictors of inhospital mortality and re-hospitalization in older adults with community-acquired pneumonia: a prospective cohort study

(2010) Binod Neupane et al.   BMC Geriatrics

Risk Factors for Community-Acquired Pneumonia in Immunocompetent Seniors

(2009) Michael L. Jackson et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality

(2009) S Ewig et al.   THORAX

BTS guidelines for the management of community acquired pneumonia in adults: update 2009

(2009) W S Lim et al.   THORAX

The aging of the immune system

(2009) Daniela Weiskopf et al.   TRANSPLANT INTERNATIONAL

The burden of community-acquired pneumonia in the elderly: the Spanish EVAN-65 Study

(2008) Olga Ochoa-Gondar et al.   BMC PUBLIC HEALTH

SMART‐COP: A Tool for Predicting the Need for Intensive Respiratory or Vasopressor Support in Community‐Acquired Pneumonia

(2008) Patrick G. P. Charles et al.   CLINICAL INFECTIOUS DISEASES

Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia

(2008) M. I. Restrepo et al.   EUROPEAN RESPIRATORY JOURNAL

Long-Term Morbidity and Mortality After Hospitalization With Community-Acquired Pneumonia

(2008) Jennie Johnstone et al.   MEDICINE

Epidemiology of community-acquired pneumonia in older adults: A population-based study

(2008) Angel Vila-Corcoles et al.   RESPIRATORY MEDICINE